Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
AQST
CTMX
Add up to 3 more stocks
AQST
Aquestive Therapeutics, Inc.
+0.75%
$4.60+0.03Delayed quote: Oct 6, 2026, 11:31 AM EDT
Market Cap
$577.70M
52W Range
$2.93 - $7.55
CTMX
CytomX Therapeutics, Inc.
+1.36%
$2.62+0.04Delayed quote: Oct 6, 2026, 11:31 AM EDT
Market Cap
$569.29M
52W Range
$2.48 - $8.21
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | N/A | 1.88 |
| P/S Ratio | 10.68 | 31.11 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 67.0% | 98.6% |
| Operating Margin | -156.4% | -29.4% |
| Net Margin | -144.6% | -435.2% |
| ROE | N/A | -26.4% |
| ROA | -59.2% | -20.9% |
| ROIC | -45.6% | -25.4% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 7.19 | 9.36 |
| Quick Ratio | 6.74 | 9.36 |
| Debt/Equity | N/A | 0.02 |
| Interest Coverage | -4.07 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.